Ad

Current Events
News in Detail
Headlines



Bilaspur District
Overview
District Administration
Major Towns
Panchayats & Villages
Organizations
Apollo Hospitals
CIMS, Bilaspur
CG High Court
GGD University
Lafarge, Arasmeta
NTPC, Seepat
NHDCRI, Sakri
SEC Railway
SECL, Bilaspur

Who's Who
By Category
By Name
By Popularity

Tit-Bits
Articles for you
Your Queries
FAQ







( News Navigation : Previous | Next | Last )

Anti-diabetic medicine - Rosiglitazone and all its formulations - suspended
09-Oct-2010 / ( Health - Previous | Next | Last )


The import and manufacture of rosiglitazone, an anti-diabetic medicine, has been suspended in the country with immediate effect, as per the order of signed by the Drug Controller General of India on 07-Oct-2010.

The order has asked all state drug controllers to suspend all the licences granted to manufacture for sale and distribution of rosiglitazone and its fixed dose combinations with other medicines with immediate effect.

The decision was taken on the basis of the recommendation of the Expert Committee as "its continued use would lead to more cardiovascular events and adverse effects on lipid profile."

Rosiglitazone and its formulations have already been suspended by European Medicines Agency last month. The U. S. Food and Drug Administration has also said that it will restrict the use of this anti-diabetic medicine to patients with Type-2 diabetes who cannot control their diabetes with other medications.




News Home About Bilaspur Site Home Back
Click on topic (below) that you want to explore

Bilaspur Business Cricket Education Entertainment
General Health International National Politics
Science Sports State Technology



Google Search:



Copyright © 2007 Data Spec. All rights reserved.
Advertise with Us | Terms of Use | Privacy Policy | Credits | Top of Page | Home
Site optimized for 1024x768 on
Internet Explorer 8 and above